CLINICAL_TRIALS
research
· 2025-02-11
Clinical Trial Update: Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria [Phase 3]
Summary
This Phase III study investigates cetirizine hydrochloride injection for acute urticaria and is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Acute Urticaria | Phase 3 | Status: RECRUITING